ACE inhibition in the treatment of children after renal transplantation
- 13 December 2003
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (2) , 222-226
- https://doi.org/10.1007/s00467-003-1317-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System InhibitionAnnals of Internal Medicine, 2002
- SUSTAINED IMPROVEMENT OF RENAL GRAFT FUNCTION FOR TWO YEARS IN HYPERTENSIVE RENAL TRANSPLANT RECIPIENTS TREATED WITH NIFEDIPINE AS COMPARED TO LISINOPRIL1Transplantation, 2001
- Short‐term pediatric renal transplant survival: Blood pressure and allograft functionPediatric Transplantation, 2001
- Arterial Hypertension and Renal Allograft SurvivalJAMA, 2000
- ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacyAmerican Journal of Kidney Diseases, 2000
- The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)Pediatric Transplantation, 1999
- ACE Inhibitor Versus β-Blocker for the Treatment of Hypertension in Renal Allograft RecipientsHypertension, 1999
- Current thinking on chronic renal allograft rejection: Issues, concerns, and recommendations from a 1997 roundtable discussionAmerican Journal of Kidney Diseases, 1999
- Treatment of kidney transplants with chronic rejection using angiotensin-converting enzyme inhibitorsTransplantation Proceedings, 1997
- Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.1996